β¨ Consent to Distribution of New Medicines
NEW ZEALAND GAZETTE, No. 34 β 21 APRIL 2016
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ipca-Allopurinol
Allopurinol 100mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ipca-Allopurinol
Allopurinol 300mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Xandane
Allopurinol 100mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Xandane
Allopurinol 300mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
Dated this 15th day of April 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go2198
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Albey Bee Venom
Bee venom 550mcg
Powder for injection with diluent
Ebos Group Limited
Jubilant Hollister-Stier LLC, Washington, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Albey Paper Wasp Venom
Wasp venom protein 550mcg
Powder for injection with diluent
Ebos Group Limited
Jubilant Hollister-Stier LLC, Washington, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Albey Yellow Jacket Venom
Wasp venom protein 550mcg
Powder for injection with diluent
Ebos Group Limited
Jubilant Hollister-Stier LLC, Washington, United States of America
Product:
Active Ingredients:
- Influenza virus A/California/7/2009 (H1N1) like strain 15mcg
- Influenza virus A/Texas/50/2012 (H3N2) like strain 15mcg
- Influenza virus B/Massachusetts/2/2012 like strain 15mcg
- Influenza virus B/Yamagata 16/88 15mcg
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Fluarix Tetra
Suspension for injection
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Biologicals (Dresden), Dresden, Germany
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare15 April 2016
Medicines, Distribution, Consent, Medicines Act 1981
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981
NZ Gazette 2016, No 34